Dactinomycin Intravenous and Kisqali Femara Co-Pack 400 mg-2.5 mg Dose
Determining the interaction of Dactinomycin Intravenous and Kisqali Femara Co-Pack 400 mg-2.5 mg Dose and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dactinomycin
Brand name: Cosmegen
Synonyms: Dactinomycin, DACTINomycin
Generic Name: letrozole / ribociclib
Brand name: Kisqali Femara Co-Pack 200 mg-25 mg Dose, Kisqali Femara Co-Pack 400 mg-25 mg Dose, Kisqali Femara Co-Pack 600 mg-25 mg Dose
Synonyms: Kisqali Femara Co-Pack 200 mg-2.5 mg Dose, Kisqali Femara Co-Pack
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dactinomycin Intravenous-Kisqali Femara Co-Pack 600 mg-2.5 mg Dose
- Dactinomycin Intravenous-Kitabis Pak
- Dactinomycin Intravenous-Kitabis Pak inhalation
- Dactinomycin Intravenous-Klofensaid II
- Dactinomycin Intravenous-Klonopin
- Dactinomycin Intravenous-Klonopin Wafer
- Kisqali Femara Co-Pack 400 mg-2.5 mg Dose-Daklinza
- Kisqali Femara Co-Pack 400 mg-2.5 mg Dose-Dalacin C Palmitate Oral
- Kisqali Femara Co-Pack 400 mg-2.5 mg Dose-Dalbavancin
- Kisqali Femara Co-Pack 400 mg-2.5 mg Dose-Dalbavancin Hydrochloride
- Kisqali Femara Co-Pack 400 mg-2.5 mg Dose-Dalbavancin Injection
- Kisqali Femara Co-Pack 400 mg-2.5 mg Dose-Dalbavancin Intravenous